Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
3876
Niu Technologies
NIU
$203M
| $138K | ﹤0.01% |
33,245
| – | – |
|
3877
DoubleVerify
DV
$1.73B
| $138K | ﹤0.01% |
4,564
+562
| +14% | +$14.7K |
|
3878
Clarus
CLAR
$123M
| $138K | ﹤0.01% |
14,561
+6,705
| +85% | +$63K |
|
|
FSP
3879
Franklin Street Properties
FSP
$47.2M
| $137K | ﹤0.01% |
87,514
-26,560
| -23% | -$66.7K |
|
3880
Humacyte
HUMA
$176M
| $137K | ﹤0.01% |
44,252
+14,145
| +47% | +$40.2K |
|
|
HCP
3881
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $137K | ﹤0.01% |
4,667
-22,336
| -83% | -$667K |
|
3882
ACNB Corp
ACNB
$656M
| $137K | ﹤0.01% |
4,196
+1,974
| +89% | +$72K |
|
3883
Five Star Bancorp
FSBC
$1.14B
| $136K | ﹤0.01% |
6,388
+3,008
| +89% | +$78K |
|
3884
Digimarc Corp
DMRC
$147M
| $136K | ﹤0.01% |
6,930
+3,259
| +89% | +$65.8K |
|
3885
Orchestra BioMed
OBIO
$238M
| $136K | ﹤0.01% |
+6,954
| New | +$80.5K |
|
3886
Bluerock Homes Trust
BHM
$35.3M
| $136K | ﹤0.01% |
6,858
+928
| +16% | +$19K |
|
|
URG
3887
Ur-Energy
URG
$485M
| $136K | ﹤0.01% |
128,100
+50,086
| +64% | +$56.6K |
|
3888
Wave Life Sciences
WVE
$1.09B
| $136K | ﹤0.01% |
31,322
-10,972
| -26% | -$50.3K |
|
|
SBOW
3889
DELISTED
SilverBow Resources, Inc.
SBOW
| $136K | ﹤0.01% |
5,932
+2,781
| +88% | +$68.7K |
|
|
OSG
3890
DELISTED
Overseas Shipholding Group Inc.
OSG
| $135K | ﹤0.01% |
+34,656
| New | +$125K |
|
3891
Nomad Foods
NOMD
$1.66B
| $135K | ﹤0.01% |
7,180
+495
| +7% | +$8.74K |
|
|
MREO
3892
Mereo BioPharma
MREO
$54.7M
| $134K | ﹤0.01% |
190,007
+23,366
| +14% | +$21K |
|
3893
Compass Therapeutics
CMPX
$344M
| $134K | ﹤0.01% |
40,986
+22,761
| +125% | +$89.4K |
|
3894
BARK
BARK
$81.8M
| $134K | ﹤0.01% |
4,621
+1,146
| +33% | +$36.3K |
|
3895
Park Aerospace
PKE
$737M
| $134K | ﹤0.01% |
9,964
+518
| +5% | +$7.3K |
|
3896
Quantum-Si Incorporated
QSI
$155M
| $134K | ﹤0.01% |
76,135
+21,850
| +40% | +$43.1K |
|
|
CMAX
3897
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $134K | ﹤0.01% |
1,669
+471
| +39% | +$55K |
|
|
STER
3898
DELISTED
Sterling Check Corp. Common Stock
STER
| $133K | ﹤0.01% |
11,970
+5,592
| +88% | +$73.6K |
|
3899
Evolv Technologies
EVLV
$995M
| $133K | ﹤0.01% |
42,712
+20,141
| +89% | +$57.5K |
|
3900
Scholar Rock
SRRK
$5.67B
| $133K | ﹤0.01% |
16,574
-17,252
| -51% | -$175K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.